Raymond Kelleher
Direttore/Membro del Consiglio presso Expansion Therapeutics, Inc.
Profilo
Dr. Raymond J.
Kelleher is a Managing Director at Cormorant Asset Management LLC/Private Equity/.
He is on the Board of Directors at Rapport Therapeutics, Inc., Garuda Therapeutics, Inc., Expansion Therapeutics, Inc., Arkuda Therapeutics, Inc., BiVACOR, Inc., GC Therapeutics, Inc. and ONK Therapeutics Ltd.
He received his undergraduate degree from Massachusetts Institute of Technology, a graduate degree from Harvard University and a doctorate degree from Stanford University.
Posizioni attive di Raymond Kelleher
Società | Posizione | Inizio |
---|---|---|
Expansion Therapeutics, Inc.
Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Direttore/Membro del Consiglio | 26/10/2022 |
Arkuda Therapeutics, Inc.
Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA. | Direttore/Membro del Consiglio | - |
BiVACOR, Inc.
BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX. | Direttore/Membro del Consiglio | - |
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Direttore/Membro del Consiglio | - |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Direttore/Membro del Consiglio | 07/02/2023 |
Cormorant Asset Management LLC/Private Equity/
Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Investitore di Private Equity | 01/07/2020 |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Direttore/Membro del Consiglio | 23/08/2023 |
GC Therapeutics, Inc.
GC Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services GC Therapeutics, Inc. is a company based in Cambridge, MA. GC Therapeutics uses synthetic biology to program stem cells into any cell type with efficiency, speed, and scalability. The company has validated cells for many applications and have developed supercells™ by tailoring cells for specific diseases. The company's goal is to bring this breakthrough approach to patients. The company was founded in 2019 by Parastoo Khoshakhlagh, Alex Ng, Cory Smith, and George McDonald Church, with Parastoo Khoshakhlagh as the CEO since 2019. | Direttore/Membro del Consiglio | - |
Formazione di Raymond Kelleher
Massachusetts Institute of Technology | Undergraduate Degree |
Harvard University | Graduate Degree |
Stanford University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 8 |
---|---|
Expansion Therapeutics, Inc.
Expansion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Expansion Therapeutics, Inc. manufactures pharmaceutical products. The company is headquartered in Del Mar, CA. | Health Technology |
Arkuda Therapeutics, Inc.
Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA. | Health Technology |
BiVACOR, Inc.
BiVACOR, Inc. Medical SpecialtiesHealth Technology BiVACOR, Inc. develops and manufactures medical device. The firm specializes in rotary blood pumps, biomedical engineering. The company was founded by Daniel Timms in 2008 and is headquartered in Houston, TX. | Health Technology |
ONK Therapeutics Ltd.
ONK Therapeutics Ltd. BiotechnologyHealth Technology ONK Therapeutics Ltd. develops bio cells for anti cancer therapies. The company was founded by Michael O'Dwyer and Anthony Killarney in 2015 and is headquartered in Galway, Ireland. | Health Technology |
Garuda Therapeutics, Inc.
Garuda Therapeutics, Inc. BiotechnologyHealth Technology Garuda Therapeutics, Inc. aims to eliminate the need for donor or patient cells for blood stem cell transplants. The company is based in Natick, MA. The company's platform technology generates off-the-shelf, self-renewing blood stem cells that are HLA-compatible and transgene-free. This technology could potentially provide curative therapies for over 120 diseases. Garuda Therapeutics was founded by Dhvanit Shah, Sean Morrison, and David T. Scadden, with Dhvanit Shah serving as CEO since incorporation. | Health Technology |
Cormorant Asset Management LLC/Private Equity/
Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Finance |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA. | Health Technology |
GC Therapeutics, Inc.
GC Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services GC Therapeutics, Inc. is a company based in Cambridge, MA. GC Therapeutics uses synthetic biology to program stem cells into any cell type with efficiency, speed, and scalability. The company has validated cells for many applications and have developed supercells™ by tailoring cells for specific diseases. The company's goal is to bring this breakthrough approach to patients. The company was founded in 2019 by Parastoo Khoshakhlagh, Alex Ng, Cory Smith, and George McDonald Church, with Parastoo Khoshakhlagh as the CEO since 2019. | Commercial Services |
- Borsa valori
- Insiders
- Raymond Kelleher